Stroke:神经电刺激(NMES)或可改善卒中后患者痉挛状态

2015-07-31 徐媛媛译 MedSci原创

神经电刺激(NMES)已经用于减少卒中患者痉挛状态并提高患者活动范围,然而临床试验的结果尚有争议性。因此,研究人员进行了一项系统回顾随机对照试验的荟萃分析旨在评估NMES联合其他干预方法是否可改善卒中后患者痉挛状态并改善关节活动范围。研究人员检索了PubMed、EMBASE、Cochrane中央对照试验数据库和物理疗法数据库等电子数据库。两位审核人员根据入选标准来评估研究的合格性(包括上下肢电刺激

神经电刺激(NMES)已经用于减少卒中患者痉挛状态并提高患者活动范围,然而临床试验的结果尚有争议性。因此,研究人员进行了一项系统回顾随机对照试验的荟萃分析旨在评估NMES联合其他干预方法是否可改善卒中后患者痉挛状态并改善关节活动范围。

研究人员检索了PubMed、EMBASE、Cochrane中央对照试验数据库和物理疗法数据库等电子数据库。两位审核人员根据入选标准来评估研究的合格性(包括上下肢电刺激的应用,并与未接受电刺激治疗的对照组进行对比),排除干预时间<3天的研究。将改良阿什沃思量表(Modified Ashworth Scale)评估的痉挛状态作为主要终点,角度计测量的活动范围作为次要终点。

在5066项研究中,共纳入29项随机临床试验,其中有940名参与者。分析显示,与对照组相比(2.87(95% CI,1.18 - -4.56),n = 13项随机临床试验),NMES可减少卒中后患者的痉挛状态(-0.30(95% CI,-0.58至-0.58,n = 14项随机临床试验),并可增加活动范围。

NMES联合其他干预方法可改善卒中后患者痉挛状态并改善关节活动范围,这也是一种治疗方式。

原始出处

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1671190, encodeId=d44e16e11902f, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Wed Nov 04 09:01:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311734, encodeId=181b1311e34d4, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393983, encodeId=70811393983e1, content=<a href='/topic/show?id=a054e00031c' target=_blank style='color:#2F92EE;'>#电刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70003, encryptionId=a054e00031c, topicName=电刺激)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTLTjicBiccpdUyHMGZV43nOBI6QIQqxVcy2EzXz67E390Q5j0R7QWjym391HxsyiaYt7NzbrcojRDw/132, createdBy=64462500151, createdName=ms705947299214030, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590773, encodeId=971a1590e736a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33950, encodeId=f05133950d3, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Aug 01 10:40:00 CST 2015, time=2015-08-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1671190, encodeId=d44e16e11902f, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Wed Nov 04 09:01:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311734, encodeId=181b1311e34d4, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393983, encodeId=70811393983e1, content=<a href='/topic/show?id=a054e00031c' target=_blank style='color:#2F92EE;'>#电刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70003, encryptionId=a054e00031c, topicName=电刺激)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTLTjicBiccpdUyHMGZV43nOBI6QIQqxVcy2EzXz67E390Q5j0R7QWjym391HxsyiaYt7NzbrcojRDw/132, createdBy=64462500151, createdName=ms705947299214030, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590773, encodeId=971a1590e736a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33950, encodeId=f05133950d3, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Aug 01 10:40:00 CST 2015, time=2015-08-01, status=1, ipAttribution=)]
    2015-08-02 apoenzyme
  3. [GetPortalCommentsPageByObjectIdResponse(id=1671190, encodeId=d44e16e11902f, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Wed Nov 04 09:01:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311734, encodeId=181b1311e34d4, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393983, encodeId=70811393983e1, content=<a href='/topic/show?id=a054e00031c' target=_blank style='color:#2F92EE;'>#电刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70003, encryptionId=a054e00031c, topicName=电刺激)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTLTjicBiccpdUyHMGZV43nOBI6QIQqxVcy2EzXz67E390Q5j0R7QWjym391HxsyiaYt7NzbrcojRDw/132, createdBy=64462500151, createdName=ms705947299214030, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590773, encodeId=971a1590e736a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33950, encodeId=f05133950d3, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Aug 01 10:40:00 CST 2015, time=2015-08-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1671190, encodeId=d44e16e11902f, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Wed Nov 04 09:01:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311734, encodeId=181b1311e34d4, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393983, encodeId=70811393983e1, content=<a href='/topic/show?id=a054e00031c' target=_blank style='color:#2F92EE;'>#电刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70003, encryptionId=a054e00031c, topicName=电刺激)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTLTjicBiccpdUyHMGZV43nOBI6QIQqxVcy2EzXz67E390Q5j0R7QWjym391HxsyiaYt7NzbrcojRDw/132, createdBy=64462500151, createdName=ms705947299214030, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590773, encodeId=971a1590e736a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33950, encodeId=f05133950d3, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Aug 01 10:40:00 CST 2015, time=2015-08-01, status=1, ipAttribution=)]
    2015-08-02 longqijun254
  5. [GetPortalCommentsPageByObjectIdResponse(id=1671190, encodeId=d44e16e11902f, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Wed Nov 04 09:01:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311734, encodeId=181b1311e34d4, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393983, encodeId=70811393983e1, content=<a href='/topic/show?id=a054e00031c' target=_blank style='color:#2F92EE;'>#电刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70003, encryptionId=a054e00031c, topicName=电刺激)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTLTjicBiccpdUyHMGZV43nOBI6QIQqxVcy2EzXz67E390Q5j0R7QWjym391HxsyiaYt7NzbrcojRDw/132, createdBy=64462500151, createdName=ms705947299214030, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590773, encodeId=971a1590e736a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Sun Aug 02 02:01:00 CST 2015, time=2015-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33950, encodeId=f05133950d3, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Aug 01 10:40:00 CST 2015, time=2015-08-01, status=1, ipAttribution=)]
    2015-08-01 保守主义

    0

相关资讯

Stroke:卒中临床试验中的困境

 临床试验中,非代表性人群如女性和少数民族参与不足会对试验的科学、经济和伦理的价值带来不好的影响。非代表性样本限制了整体试验的安全性和有效性。早在1993年,美国国立卫生研究院(NIH)就推出了振兴法案PL103-43,要求在NIH资助的临床试验中样本要具有代表性。尽管有这个法案的干预,但是许多试验的样本仍然不是最佳的,尤其在神经学临床试验中。在卒中临床试验中,少数民族受试者的召集和保留

新型口服抗凝药预防亚洲人群非瓣膜房颤患者卒中的优势

首先张玉生教授介绍了亚洲AF患者的特点和传统抗栓治疗。根据流行病学调查研究显示亚洲AF疾病负荷将持续增加,尤其是中国,到2050年中国男性房颤患者将达到250万,女性房颤患者将达到310万。多个大型RCT研究(如RE-LY、ROCKET、ARISTOTLE、ENGAGE)或注册研究(如REALISE、RELY、RECORD)结果均显示亚洲AF患者

JAMA:卒中加快了认知能力的下降,并且影响时间长

    认知能力下降是卒中患者残疾的主要病因。卒中后幸存者的认知变化的幅度是不确定的。该研究的目的是为了探讨卒中事件幸存者中认知功能的变化,为他们卒中前认知的轨迹进行控制。    该前瞻性研究共有23572名≥45岁的参与者,这些参与者来自于卒中的地理和种族差异的原因(REGARDS)队列,并且无基线的认知障碍,居住在美国大陆,2003-2007招募进来并随

Stroke:女性缺血性卒中联用尿酸治疗效果更佳

 由于高耗氧导致的氧化损伤对于缺血性脑损伤有很大的危害。尿酸是嘌呤代谢的最终产物,是一种潜在的抗氧化物。尿酸的作用包括了清楚羟基自由基、过氧化氢和过氧硝酸盐等。目前,治疗急性缺血性卒中使用抗氧化药物和血栓溶解药物组合的处方,但是男女对这一处方是否有着相同的响应尚未明确。因此,研究人员分析了使用阿替普酶治疗急性缺血性卒中的患者对于尿酸疗法的响应的性别差异。在一项联用尿酸的临床试验中,206

JAMA:过度室上性异位搏动(ESVEA)增加了缺血性卒中的风险

    大约有30%的缺血性中风都有一个未知的原因。增加房性早搏(AE)会增加心房颤动(AF)的风险,但中风的患者的增加的AE的风险是未知的。    本研究旨在探讨增加AE和短期心脏收缩是否增加房颤事件之外的中风风险。    数据来自于哥本哈根动态队列研究15年的随访,该研究包括55至75岁之间的678名男性和女性,这些参与者没有早期心血

Stroke:心房颤动类型不同,心血管疾病和卒中风险不同

心房颤动(AF)会增加卒中和全身性栓塞(SSE)的风险,这直接导致了发病率和死亡率的上升。卒中的风险是否被AF的类型、持续时间和频率影响,这已经在学术界争论了数十年。AF和心脏衰竭频繁地共存,并且和增高的发病率和死亡率有关。科研人员研究了患有持续性AF和非持续性AF的接受抗凝治疗的病人的预后。这项研究是根据AMADEUS试验(与华法林或新抗凝对比,评价AF病人的SR34006的使用)中已经存在的心